ATE391123T1 - Triazole als farnesyl-transferase-hemmer - Google Patents
Triazole als farnesyl-transferase-hemmerInfo
- Publication number
- ATE391123T1 ATE391123T1 AT00988714T AT00988714T ATE391123T1 AT E391123 T1 ATE391123 T1 AT E391123T1 AT 00988714 T AT00988714 T AT 00988714T AT 00988714 T AT00988714 T AT 00988714T AT E391123 T1 ATE391123 T1 AT E391123T1
- Authority
- AT
- Austria
- Prior art keywords
- substituted
- aryl
- unsubstituted
- hydroxyc1
- 6alkylthio
- Prior art date
Links
- 239000003528 protein farnesyltransferase inhibitor Substances 0.000 title 1
- 150000003852 triazoles Chemical class 0.000 title 1
- 125000003118 aryl group Chemical group 0.000 abstract 10
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 6
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 abstract 4
- 125000004104 aryloxy group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical group O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000001424 substituent group Chemical group 0.000 abstract 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Paints Or Removers (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16543499P | 1999-11-15 | 1999-11-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE391123T1 true ATE391123T1 (de) | 2008-04-15 |
Family
ID=22598878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00988714T ATE391123T1 (de) | 1999-11-15 | 2000-11-15 | Triazole als farnesyl-transferase-hemmer |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US7511061B2 (de) |
| EP (1) | EP1232147B1 (de) |
| JP (1) | JP4883862B2 (de) |
| AT (1) | ATE391123T1 (de) |
| AU (1) | AU779426B2 (de) |
| CA (1) | CA2389280C (de) |
| DE (1) | DE60038498T2 (de) |
| ES (1) | ES2304996T3 (de) |
| WO (1) | WO2001036395A1 (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE391123T1 (de) | 1999-11-15 | 2008-04-15 | Janssen Pharmaceutica Nv | Triazole als farnesyl-transferase-hemmer |
| US7049324B1 (en) | 1999-11-15 | 2006-05-23 | Ashis Kumar Saha | Triazoles as farnesyl transferase inhibitors |
| US6774134B2 (en) | 2000-12-20 | 2004-08-10 | Bristol-Myers Squibb Company | Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
| US6919331B2 (en) | 2001-12-10 | 2005-07-19 | Bristol-Myers Squibb Company | Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents |
| AP2007004047A0 (en) | 2005-01-20 | 2007-06-30 | Pfizer Ltd | Substituted triazole derivatives as oxtocin antagonists |
| RU2415134C9 (ru) * | 2005-08-15 | 2011-05-27 | Этерна Центарис ГмбХ | Способ лечения или профилактики физиологических и/или патофизиологических состояний, опосредуемых рецепторами, стимулирующими секрецию гормона роста, триазолы и фармацевтическая композиция на их основе |
| EP1757290A1 (de) | 2005-08-16 | 2007-02-28 | Zentaris GmbH | Triazolderivate als Liganden der Wachstumshormonrezeptoren |
| UY30118A1 (es) * | 2006-01-31 | 2007-06-29 | Tanabe Seiyaku Co | Compueto amina trisustituido |
| EP1958631A1 (de) * | 2007-02-14 | 2008-08-20 | AEterna Zentaris GmbH | Neue Triazolderivate als Liganden von G-Protein-gekoppelten Rezeptoren |
| TWI448284B (zh) * | 2007-04-24 | 2014-08-11 | Theravance Inc | 雙效抗高血壓劑 |
| EP2103602A1 (de) | 2008-03-17 | 2009-09-23 | AEterna Zentaris GmbH | Neuartige 1,2,4-Triazol-Derivate und Herstellungsverfahren dafür |
| US8466290B2 (en) | 2008-07-10 | 2013-06-18 | Pharma Ip General Incorporated Association | STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient |
| ES2352398B1 (es) | 2009-06-25 | 2011-09-29 | Institut Univ. De Ciencia I Tecnologia S.A. | N-fenetilsulfonamidas-n-sustituidas para la identificacion de actividad biologica y farmacologica. |
| EP2431035A1 (de) | 2010-09-16 | 2012-03-21 | Æterna Zentaris GmbH | Neue Triazolderivate mit verbesserter Rezeptoraktivität und Bioverfügbarkeitseigenschaften als Ghrelin-Antagonisten der Wachstumshormon-Sekretagogum-Rezeptoren |
| MX2015014688A (es) * | 2013-04-22 | 2016-02-19 | Abbvie Inc | Tiazoles y usos de los mismos. |
| US10781178B2 (en) | 2015-08-12 | 2020-09-22 | The General Hospital Corporation | 8-hydroxyquinoline derivatives as diagnostic and therapeutic agents |
| PY1986700A (es) * | 2018-10-19 | 2020-08-28 | Syngenta Participations Ag | Compuestos de azol-amida pesticidamente activos |
| JP2022538155A (ja) * | 2019-06-26 | 2022-08-31 | ウエヌイグレックオ・ファーマ | 第三級アミン誘導体及びウイルス感染症の治療のためのそれらの使用 |
| TW202508595A (zh) | 2023-05-04 | 2025-03-01 | 美商銳新醫藥公司 | 用於ｒａｓ相關疾病或病症之組合療法 |
| US20250049810A1 (en) | 2023-08-07 | 2025-02-13 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| AU2024360465A1 (en) | 2023-10-12 | 2026-04-09 | Revolution Medicines, Inc. | Macrocyclic ras inhibitors |
| WO2025171296A1 (en) | 2024-02-09 | 2025-08-14 | Revolution Medicines, Inc. | Ras inhibitors |
| TW202547461A (zh) | 2024-05-17 | 2025-12-16 | 美商銳新醫藥公司 | Ｒａｓ抑制劑 |
| WO2025265060A1 (en) | 2024-06-21 | 2025-12-26 | Revolution Medicines, Inc. | Therapeutic compositions and methods for managing treatment-related effects |
| WO2026006747A1 (en) | 2024-06-28 | 2026-01-02 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026015801A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015790A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015796A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015825A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Use of ras inhibitor for treating pancreatic cancer |
| WO2026050446A1 (en) | 2024-08-29 | 2026-03-05 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026072904A2 (en) | 2024-09-26 | 2026-04-02 | Revolution Medicines, Inc. | Compositions and methods for treating lung cancer |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE787762A (fr) * | 1971-08-21 | 1973-02-19 | Bayer Ag | Colorants cationiques |
| JPS5761741B2 (de) * | 1974-02-15 | 1982-12-25 | Yoshitomi Pharmaceutical | |
| US4243408A (en) * | 1978-05-11 | 1981-01-06 | Chevron Research Company | Herbicidal N-triazolylmethyl-substituted alpha-haloacetanilide |
| DE2854598A1 (de) * | 1978-12-18 | 1980-07-03 | Basf Ag | N-substituierte carbonsaeureanilide, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide |
| DE3238006A1 (de) * | 1982-10-13 | 1984-04-19 | Bayer Ag, 5090 Leverkusen | Azolyl-methylamine, ihre herstellung und verwendung in mikrobiziden mitteln |
| DE3320996A1 (de) * | 1983-06-10 | 1984-12-20 | Celamerck Gmbh & Co Kg, 6507 Ingelheim | Heterocyclische verbindungen, ihre herstellung und verwendung |
| GB8408617D0 (en) * | 1984-04-04 | 1984-05-16 | Ciba Geigy Ag | Metal deactivators |
| JPH0696576B2 (ja) * | 1988-05-23 | 1994-11-30 | 吉富製薬株式会社 | チエニルアゾール化合物 |
| US5217985A (en) * | 1990-08-28 | 1993-06-08 | G. D. Searle & Co. | Renal-selective biphenylalkyl 1h-substituted-1,2,4-triazole angiotensin ii antagonists for treatment of hypertension |
| JPH05201990A (ja) * | 1991-10-16 | 1993-08-10 | Asahi Chem Ind Co Ltd | 新規なナフタレン誘導体 |
| JPH05241331A (ja) * | 1992-02-26 | 1993-09-21 | Fuji Photo Film Co Ltd | 光重合性組成物 |
| GB9211193D0 (en) * | 1992-05-27 | 1992-07-08 | Merck Sharp & Dohme | Therapeutic agents |
| JPH06263742A (ja) * | 1992-10-21 | 1994-09-20 | Sankyo Co Ltd | アゾール化合物 |
| JP3714684B2 (ja) * | 1993-07-02 | 2005-11-09 | 城北化学工業株式会社 | ベンゾトリアゾール誘導体 |
| US5710171A (en) * | 1995-05-24 | 1998-01-20 | Merck & Co., Inc. | Bisphenyl inhibitors of farnesyl-protein transferase |
| GB9604311D0 (en) * | 1996-02-29 | 1996-05-01 | Merck & Co Inc | Inhibitors of farnesyl-protein transferase |
| JP2000505797A (ja) * | 1996-01-30 | 2000-05-16 | メルク エンド カンパニー インコーポレーテッド | ファルネシル―タンパク質転移酵素の阻害剤 |
| US5780488A (en) * | 1996-04-03 | 1998-07-14 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| CA2249665A1 (en) * | 1996-04-03 | 1997-10-09 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| WO1997036585A1 (en) * | 1996-04-03 | 1997-10-09 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5891889A (en) * | 1996-04-03 | 1999-04-06 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5874452A (en) * | 1996-04-03 | 1999-02-23 | Merck & Co., Inc. | Biheteroaryl inhibitors of farnesyl-protein transferase |
| US5872136A (en) * | 1996-04-03 | 1999-02-16 | Merck & Co., Inc. | Arylheteroaryl inhibitors of farnesyl-protein transferase |
| US5883105A (en) * | 1996-04-03 | 1999-03-16 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| AU716381B2 (en) * | 1996-04-03 | 2000-02-24 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5880140A (en) * | 1996-04-03 | 1999-03-09 | Merck & Co., Inc. | Biheteroaryl inhibitors of farnesyl-protein transferase |
| US5854265A (en) * | 1996-04-03 | 1998-12-29 | Merck & Co., Inc. | Biheteroaryl inhibitors of farnesyl-protein transferase |
| US5939557A (en) * | 1996-04-03 | 1999-08-17 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5850086A (en) * | 1996-06-21 | 1998-12-15 | Regents Of The University Of Minnesota | Iron complexes for bleach activation and stereospecific oxidation |
| US5854264A (en) * | 1996-07-24 | 1998-12-29 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5869579A (en) * | 1996-11-13 | 1999-02-09 | Warner-Lambert Company | Solid phase preparation of amines |
| US5932590A (en) * | 1996-12-05 | 1999-08-03 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| CA2276081A1 (en) * | 1996-12-30 | 1998-07-09 | Lekhanh O. Tran | Inhibitors of farnesyl-protein transferase |
| US5939439A (en) * | 1996-12-30 | 1999-08-17 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| ES2189918T3 (es) * | 1997-02-21 | 2003-07-16 | Shenyang Res Inst Chemical Ind | Agentes antimicrobianos de difenilacrilamida que contienen fluor. |
| TW591030B (en) | 1997-03-10 | 2004-06-11 | Janssen Pharmaceutica Nv | Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles |
| CA2288789C (en) * | 1997-05-08 | 2009-07-21 | Merck Sharp & Dohme Limited | Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as gaba alpha 5 ligands |
| US6297239B1 (en) * | 1997-10-08 | 2001-10-02 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
| US7049324B1 (en) * | 1999-11-15 | 2006-05-23 | Ashis Kumar Saha | Triazoles as farnesyl transferase inhibitors |
| ATE391123T1 (de) | 1999-11-15 | 2008-04-15 | Janssen Pharmaceutica Nv | Triazole als farnesyl-transferase-hemmer |
-
2000
- 2000-11-15 AT AT00988714T patent/ATE391123T1/de not_active IP Right Cessation
- 2000-11-15 JP JP2001538884A patent/JP4883862B2/ja not_active Expired - Fee Related
- 2000-11-15 AU AU25063/01A patent/AU779426B2/en not_active Ceased
- 2000-11-15 WO PCT/EP2000/011393 patent/WO2001036395A1/en not_active Ceased
- 2000-11-15 DE DE60038498T patent/DE60038498T2/de not_active Expired - Lifetime
- 2000-11-15 CA CA002389280A patent/CA2389280C/en not_active Expired - Fee Related
- 2000-11-15 ES ES00988714T patent/ES2304996T3/es not_active Expired - Lifetime
- 2000-11-15 EP EP00988714A patent/EP1232147B1/de not_active Expired - Lifetime
-
2005
- 2005-06-02 US US11/143,814 patent/US7511061B2/en not_active Expired - Lifetime
-
2007
- 2007-10-29 US US11/926,858 patent/US7592356B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7511061B2 (en) | 2009-03-31 |
| US7592356B2 (en) | 2009-09-22 |
| WO2001036395A1 (en) | 2001-05-25 |
| DE60038498T2 (de) | 2009-05-07 |
| US20050234117A1 (en) | 2005-10-20 |
| CA2389280C (en) | 2009-01-27 |
| DE60038498D1 (de) | 2008-05-15 |
| AU779426B2 (en) | 2005-01-27 |
| JP4883862B2 (ja) | 2012-02-22 |
| CA2389280A1 (en) | 2001-05-25 |
| AU2506301A (en) | 2001-05-30 |
| ES2304996T3 (es) | 2008-11-01 |
| US20080103150A1 (en) | 2008-05-01 |
| JP2003514804A (ja) | 2003-04-22 |
| EP1232147A1 (de) | 2002-08-21 |
| EP1232147B1 (de) | 2008-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE391123T1 (de) | Triazole als farnesyl-transferase-hemmer | |
| CY1106237T1 (el) | Ετepοκυκλικα παραγωγα με 5 μελη στο δακτυλιο και εφαρμογη αυτων ως παρεμποδιστων της μονοαμινο οξυδασης | |
| AR021297A1 (es) | 2-fenilbenzimidazoles y 2-fenilindoles, su preparacion y aplicacion | |
| UY25986A1 (es) | Complejo del inhibidor de ras-farnesiltransferasa y sulfobutiléter-7-beta-ciclodextrina o 2-hidroxipropil-beta-ciclodextrina y método. | |
| PE22795A1 (es) | Derivado antitrombotico de amidinofenilalanina y amidinopiridilalanina | |
| DK1106179T3 (da) | Anvendelse af östrogenantagonister og östrogenagonister til hæmning af patologiske tilstande | |
| HUP0003355A2 (hu) | Tieno[2,3-d]pirimidindion-származékok és ezeket tartalmazó gyógyszerkészítmények, eljárás előállításukra és alkalmazásuk | |
| AR014191A1 (es) | Compuestos de 3-benziloxipirazol; composiciones formuladas con dichos compuestos, utiles en la supresion de hongos fitopatogenos; procesos curativoso preventivos de infecciones fitopatogenas; procedimiento para preparar dichos compuestos y compuestos de 3-hidroxipirazol utiles como intermediarios de | |
| ATE88714T1 (de) | 2'-desoxy-5-fluoruridinderivate. | |
| DK270983D0 (da) | 1-aryloxy-2,3,4,5-tetrahydro-3--benzazepiner, en fremgangsmade til fremstilling deraf og deres anvendelse | |
| MX9800412A (es) | Preparacion de 3-hidroxipirazoles n-substituidos. | |
| TW352383B (en) | Hydroximic acid derivatives, processes for their preparation, and compositions comprising them | |
| MX9400194A (es) | Materiales fototermograficos. | |
| ATE46159T1 (de) | Pyridazinone, inotrope mittel. | |
| ES2177816T3 (es) | Derivados de azahexano como isosteros de sustrato de aspartato proteasas retroviricas. | |
| DK0579059T3 (da) | Pyridazinonderivater og fremgangsmåder til fremstilling af samme | |
| BR9916314A (pt) | Inibidores tricìclicos da proteìna farnesil transferase | |
| DK193090D0 (da) | Imidazolyl- og pyridylderivater af phenylsubstituerede 1,4-dihydropyridiner og fremgangsmaade til fremstilling deraf | |
| DK0630893T3 (da) | N,N'-disubstitueret amidderivat | |
| DE69924298D1 (de) | Stabilisierungsmittel | |
| WO1999059996A8 (en) | Antitumour 1,5-diazaanthraquinones | |
| AR041654A1 (es) | Compuestos (1,4) benzodioxino(2,3-e)isoindol sustituidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen | |
| BR9307392A (pt) | Benzimidazóis substituìdos | |
| CO5140090A1 (es) | Derivados de pirazol, su preparacion y su aplicacion en terapeutica | |
| FR2611715B1 (fr) | Nouveaux acetamides derives de la dihydro-2,3 phenyl-3 benzofurannone-2, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |